Leerink Swann downgraded Corcept Therapeutics (NASDAQ: CORT) from Outperform to Market Perform.

Leerink analyst says, "Over the weekend, CORT presented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE